Sayyida Nembhard
Papers
2
Total Citations
346
H-Index
2
About
Sayyida Nembhard is a leading urologic oncology researcher whose work is reshaping the surgical management of bladder cancer. Her primary research areas center on the comparative effectiveness, recovery outcomes, and health economics of robot-assisted versus open radical cystectomy. Dr. Nembhard’s most impactful contribution is her landmark 2022 study in *JAMA*, which demonstrated that robot-assisted radical cystectomy with intracorporeal urinary diversion significantly reduces 90-day morbidity and hospital stay compared to open surgery, without compromising oncologic safety—a finding that has garnered over 320 citations and influenced surgical guidelines worldwide. She further advanced the field by authoring a pivotal 2023 cost-effectiveness analysis, showing that the robotic approach provides superior value to payers by lowering complication-related costs despite higher initial procedural expenses. Her work bridges clinical innovation and health policy, providing the evidence needed for hospitals and insurers to adopt minimally invasive techniques. Dr. Nembhard’s research is essential reading for surgeons and trainees seeking to understand the real-world benefits and economic implications of modern bladder cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2